| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
|
Nat Genet
|
2009
|
15.15
|
|
2
|
Genotype, haplotype and copy-number variation in worldwide human populations.
|
Nature
|
2008
|
12.40
|
|
3
|
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
|
Nat Genet
|
2011
|
9.23
|
|
4
|
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
|
Brain
|
2009
|
4.01
|
|
5
|
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
|
Lancet Neurol
|
2008
|
3.03
|
|
6
|
Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p.
|
J Neurol
|
2010
|
2.75
|
|
7
|
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.
|
PLoS One
|
2010
|
2.57
|
|
8
|
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.
|
Hum Mol Genet
|
2012
|
1.68
|
|
9
|
Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal.
|
Neurobiol Aging
|
2007
|
1.67
|
|
10
|
Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease.
|
Nat Rev Neurosci
|
2012
|
1.58
|
|
11
|
Insights into TREM2 biology by network analysis of human brain gene expression data.
|
Neurobiol Aging
|
2013
|
1.49
|
|
12
|
NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases.
|
Neurobiol Aging
|
2014
|
1.32
|
|
13
|
Complement receptor 1 (CR1) and Alzheimer's disease.
|
Immunobiology
|
2011
|
1.30
|
|
14
|
Mutant ADA2 in vasculopathies.
|
N Engl J Med
|
2014
|
1.20
|
|
15
|
Screening for VPS35 mutations in Parkinson's disease.
|
Neurobiol Aging
|
2011
|
1.12
|
|
16
|
Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.
|
JAMA Neurol
|
2013
|
1.09
|
|
17
|
PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit.
|
Hum Mutat
|
2010
|
1.07
|
|
18
|
TREM2 and neurodegenerative disease.
|
N Engl J Med
|
2013
|
1.06
|
|
19
|
SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis.
|
JAMA Neurol
|
2013
|
1.05
|
|
20
|
Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series.
|
Neurobiol Aging
|
2010
|
1.04
|
|
21
|
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.
|
J Alzheimers Dis
|
2012
|
1.02
|
|
22
|
Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci.
|
Ann Hum Genet
|
2013
|
1.02
|
|
23
|
Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration.
|
Neurobiol Aging
|
2009
|
1.01
|
|
24
|
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.
|
Hum Mol Genet
|
2012
|
0.93
|
|
25
|
A novel A781V mutation in the CSF1R gene causes hereditary diffuse leucoencephalopathy with axonal spheroids.
|
J Neurol Sci
|
2013
|
0.91
|
|
26
|
Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2.
|
BMC Neurol
|
2008
|
0.91
|
|
27
|
Tau acts as an independent genetic risk factor in pathologically proven PD.
|
Neurobiol Aging
|
2012
|
0.86
|
|
28
|
NOTCH3 variants and risk of ischemic stroke.
|
PLoS One
|
2013
|
0.84
|
|
29
|
Identification of Stk25 as a genetic modifier of Tau phosphorylation in Dab1-mutant mice.
|
PLoS One
|
2012
|
0.80
|
|
30
|
Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort.
|
Neurobiol Aging
|
2012
|
0.78
|
|
31
|
Clusterin as an Alzheimer biomarker.
|
Arch Neurol
|
2011
|
0.77
|
|
32
|
A new way APP mismetabolism can lead to Alzheimer's disease.
|
EMBO Mol Med
|
2011
|
0.75
|